Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

TTK Healthcare Ltd

TTKHLTCARE

TTK Healthcare Ltd

TTKHLTCARE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,155 cr, stock is ranked 1,113
Moderate RiskStock is 2.14x as volatile as Nifty
1,525.751.71% (-26.60)
1,525.751.71% (-26.60)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,155 cr, stock is ranked 1,113
Moderate RiskStock is 2.14x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,155 cr, stock is ranked 1,113
Moderate RiskStock is 2.14x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
26.972.150.66%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.276.550.51%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

TTK Healthcare Limited is engaged in pharmaceuticals, consumer products, medical devices and foods businesses.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.11%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.29% to 0.22%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 20.87%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue524.46533.54585.12635.63654.55503.75641.141,368.49815.40857.75
Raw Materialssubtract230.73244.31241.51268.36273.84207.56293.87352.49348.85738.41
Power & Fuel Costsubtract6.547.3612.5713.5615.0013.4415.8319.8421.79
Employee Costsubtract81.4287.99120.12130.70143.9493.70102.84123.38132.84
Selling & Administrative Expensessubtract148.64136.46143.03151.70177.20121.58155.31165.89181.63
Operating & Other expensessubtract11.0613.2117.7714.017.4920.459.5632.1630.35
Depreciation/Amortizationsubtract7.2111.9215.2414.6714.3813.0212.5812.8113.0610.68
Interest & Other Itemssubtract3.333.114.733.383.271.713.245.242.762.76
Taxes & Other Itemssubtract12.8610.4411.9814.897.11-14.166.3316.9721.2825.97
EPS29.1924.1316.6017.248.7232.8729.43452.7244.4756.57
DPS5.005.005.005.003.006.0010.0010.0010.0010.00
Payout ratio0.170.210.300.290.340.180.340.020.220.18
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
TTK Healthcare Ltd34.312.150.66%
Sun Pharmaceutical Industries Ltd45.346.470.75%
Cipla Ltd31.214.800.82%
Torrent Pharmaceuticals Ltd65.3815.800.88%

Price Comparison

Compare TTKHLTCARE with any stock or ETF
Compare TTKHLTCARE with any stock or ETF
TTKHLTCARE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Decreased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.79%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding74.56%0.00%1.13%1.90%22.40%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep2.40%1.85%1.85%1.85%1.87%1.90%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

TTKHLTCARE has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.64%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.38 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 16, 2024

Final
Final | Div/Share: ₹10.00

Dividend/Share

₹10.00

Ex DateEx Date

Jul 16, 2024

Cash Dividend

Ex DateEx DateJul 18, 2023

Final
Final | Div/Share: ₹10.00

Dividend/Share

₹10.00

Ex DateEx Date

Jul 18, 2023

Cash Dividend

Ex DateEx DateJul 26, 2022

Final
Final | Div/Share: ₹10.00

Dividend/Share

₹10.00

Ex DateEx Date

Jul 26, 2022

Cash Dividend

Ex DateEx DateAug 12, 2021

Final
Final | Div/Share: ₹6.00

Dividend/Share

₹6.00

Ex DateEx Date

Aug 12, 2021

Cash Dividend

Ex DateEx DateSep 3, 2020

Final
Final | Div/Share: ₹3.00

Dividend/Share

₹3.00

Ex DateEx Date

Sep 3, 2020

News & Opinions
Earnings
TTK Healthcare standalone net profit rises 7.43% in the September 2024 quarter

Net profit of TTK Healthcare rose 7.43% to Rs 17.20 crore in the quarter ended September 2024 as against Rs 16.01 crore during the previous quarter ended September 2023. Sales rose 6.85% to Rs 198.49 crore in the quarter ended September 2024 as against Rs 185.77 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales198.49185.77 7 OPM %4.155.14 - PBDT25.1924.84 1 PBT23.1921.56 8 NP17.2016.01 7 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
TTK Healthcare to conduct board meeting

TTK Healthcare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live

3 weeks agoCapital Market - Live

TTK Healthcare standalone net profit rises 101.53% in the June 2024 quarter

3 months agoBusiness Standard
Earnings
TTK Healthcare standalone net profit rises 101.53% in the June 2024 quarter

Net profit of TTK Healthcare rose 101.53% to Rs 31.58 crore in the quarter ended June 2024 as against Rs 15.67 crore during the previous quarter ended June 2023. Sales rose 2.86% to Rs 207.90 crore in the quarter ended June 2024 as against Rs 202.12 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales207.90202.12 3 OPM %3.324.97 - PBDT23.0823.80 -3 PBT21.0320.64 2 NP31.5815.67 102 Powered by Capital Market - Live

3 months agoCapital Market - Live

TTK Healthcare hits record high after PAT soars to Rs 31 cr in Q1 FY25

3 months agoBusiness Standard
Spotlight
TTK Healthcare hits record high after PAT soars to Rs 31 cr in Q1 FY25

Revenue from operations increased 2.86% YoY to Rs 207.90 crore in Q1 FY25. Profit before tax (PBT) jumped 97.72% YoY to Rs 40.79 crore during the quarter. On segmental front, revenue from Animal Welfare stood at Rs 31.11 crore (up 14.25% YoY), revenue from consumer products was at Rs 73.14 crore (up 2.77%YoY), revenue from medical devices stood at Rs 24.57 crore (up 10.63%YoY) while revenue from protective devices stood at Rs 46.28 crore ( down 10.07% YoY) during the period under review. TTK Healthcare distribution of Consumer Products, Animal Welfare Products, Food Products, Medical Devices and Protective Devices. The scrip hit an all time high at Rs 1,800 in intraday today.Powered by Capital Market - Live

3 months agoCapital Market - Live

TTK Healthcare posts Q1 net profit of ₹16 crore

1 year agoThe Hindu Businessline

TTK Healthcare Q1 net profit from continuing business quadruples

1 year agoThe Hindu

TTK Healthcare shares will continue to be listed

1 year agoThe Hindu

TTK Healthcare says delisting offer failed; shares tendered in buyback to be credited back to public shareholders

1 year agoThe Hindu Businessline